Δ9-Canrenone
CAS: 95716-71-5
Ref. 3D-VDA71671
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
Δ9-Canrenone
Sinónimos:
- 17-Hydroxy-3-oxopregn-4,6,9-triene-21-carboxylic acid gamma-lactone
- 17α-Pregna-4,6,9(11)-triene-21-carboxylic acid, 17-hydroxy-3-oxo-, γ-lactone
- 17β-Hydroxy-4,6,9(11)-trien-3-one 21-carboxylic acid γ-lactone
- Pregna-4,6,9(11)-triene-21-carboxylic acid, 17-hydroxy-3-oxo-, γ-lactone, (17α)-
- Spiro[17H-cyclopenta[a]phenanthrene-17,2′(5′H)-furan], pregna-4,6,9(11)-triene-21-carboxylic acid deriv.
- Δ<sup>9-11</sup>-Canrenone
- Δ<sup>9</sup>-Canrenone
- Delta 9,11-canrenone
- Δ9-11-Canrenone
Descrição:
Δ9-Canrenone is a reagent that is used in the preparation of eplerenone, a steroidal anti-hypertensive drug. It is synthesized from canrenoic acid by lactonization and conversion to its methyl ester. The methyl ester is then converted to the corresponding epoxide. The epoxide reacts with boron trifluoride etherate to produce an intermediate which undergoes a cyclization reaction with furyl chloride and methanol to yield Δ9-canrenone. This compound has been found in environmental samples as a result of industrial pollution and as an end product of the metabolism of steroids by bacteria.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
338.4 g/mol
Fórmula:
C22H26O3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
